RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 A Randomized Phase 3 Trial of Intraperitoneal Cisplatin and Early Mitomycin C plus Long-Term Doxifluridine plus Cisplatin versus Mitomycin C plus Short-Term Doxifluridine
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 4
SP 14
OP 15
DO 10.1177/155989770800800411
UL http://mdc.sagepub.com/content/8/4/14.abstract
AB In patients with grossly serosa-positive advanced gastric cancer, postoperative adjuvant chemotherapy with intraperitoneal cisplatin and early mitomycin C (M) plus long-term doxifluridine plus cisplatin (iceMFP) improved recurrence-free and overall survival. The comparator regimen in the phase 3 trial [AMC 0101] was M plus short-term doxifluridine.